325 results on '"Angermann, Christiane E."'
Search Results
2. Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study
3. Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry
4. Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial
5. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
6. Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF
7. Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post‐hoc analysis from EMPULSE.
8. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study
9. Don't put too much weight on weight telemonitoring in high‐risk heart failure patients!
10. Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction – Results from the EMPULSE trial.
11. Prevalence of anti‐beta‐1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcome
12. Remote heart failure management guided by pulmonary artery pressure home monitoring: rewriting the future?
13. Hospitalization for acute heart failure during non‐working hours impacts on long‐term mortality: the REPORT‐HF registry
14. Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE
15. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT‐HF
16. The Win Ratio Method in Heart Failure Trials: Lessons Learnt From Empulse
17. Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry
18. Association of time-to-intravenous furosemide with mortality in acute heart failure : data from REPORT-HF
19. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF
20. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of <scp>REPORT‐HF</scp>
21. Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
22. Effects of remote haemodynamic‐guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS‐HF study
23. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
24. Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial
25. Quality of life assessed six months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (International Registry to assess mEdical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)
26. Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring
27. Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS-HF study
28. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure:a multinational randomized trial
29. Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)
30. Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction
31. Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension:insights from the MEMS-HF study
32. A global perspective of racial differences and outcomes in patients presenting with acute heart failure
33. Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry
34. Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring
35. Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring
36. Prognostic potential of midregional pro‐adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides
37. A functional variant of the neuropeptide S receptor‐1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study
38. Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT‐HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure)
39. Global disparities in prescription of guideline-recommended drugs for heart failure with reduced ejection fraction
40. Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany
41. Sex-specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure
42. A global perspective of racial differences and outcomes in patients presenting with acute heart failure
43. EMPAGLIFLOZIN IN PATIENTS HOSPITALIZED FOR DE NOVO VERSUS DECOMPENSATED CHRONIC HEART FAILURE: INSIGHTS FROM THE EMPULSE TRIAL
44. Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT‐HF registry
45. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
46. Sex‐specific bimodal clustering of left ventricular ejection fraction in patients with acute heart failure
47. Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring
48. International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry
49. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling
50. Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.